| (-)-Blebbistcitin |
674289-55-5 |
.... |
| A966492 |
934162-61-5 |
A-966492 is a potent poly(ADP-Ribose) polymerase (PARP) inhibitor.... |
| A966492 |
934162-61-5 |
A-966492 is a potent poly(ADP-Ribose) polymerase (PARP) inhibitor.... |
| A966492 |
934162-61-5 |
A-966492 is a potent poly(ADP-Ribose) polymerase (PARP) inhibitor.... |
| A966492 |
934162-61-5 |
A-966492 is a potent poly(ADP-Ribose) polymerase (PARP) inhibitor.... |
| ABR-215050 |
254964-60-8 |
ABR-215050 is a quinoline-3-carboxamide anti-angiogenic agent.... |
| ACY-1215 |
1316214-52-4 |
ACY-1215 is a histone deacetylase (HDAC) 6-selective inhibitor.... |
| ACY-1215 |
1316214-52-4 |
ACY-1215 is a histone deacetylase (HDAC) 6-selective inhibitor.... |
| ACY-1215 |
1316214-52-4 |
ACY-1215 is a histone deacetylase (HDAC) 6-selective inhibitor.... |
| ACY-1215 |
1316214-52-4 |
ACY-1215 is a histone deacetylase (HDAC) 6-selective inhibitor.... |
| AG-014699 |
459868-92-9 |
AG-014699 is a potent inhibitor of Poly (ADP-ribose) polymerase (PARP) with Ki values of 1.4 and 0.17 nM for PARP-1 and PARP-2, respectively.... |
| AG-014699 |
459868-92-9 |
AG-014699 is a potent inhibitor of Poly (ADP-ribose) polymerase (PARP) with Ki values of 1.4 and 0.17 nM for PARP-1 and PARP-2, respectively.... |
| AG-014699 |
459868-92-9 |
AG-014699 is a potent inhibitor of Poly (ADP-ribose) polymerase (PARP) with Ki values of 1.4 and 0.17 nM for PARP-1 and PARP-2, respectively.... |
| AG-014699 |
459868-92-9 |
AG-014699 is a potent inhibitor of Poly (ADP-ribose) polymerase (PARP) with Ki values of 1.4 and 0.17 nM for PARP-1 and PARP-2, respectively.... |
| AG014699 |
283173-50-2 |
.... |
| AG014699 |
283173-50-2 |
.... |
| AG014699 |
283173-50-2 |
.... |
| AG014699 |
283173-50-2 |
.... |
| AG14361 |
328543-09-5 |
AG14361 is a potent PARP1 inhibitor with Ki of <5 nM.... |
| AZD1152-HQPA |
722544-51-6 |
AZD1152-HQPA is a specific inhibitor of the enzymatic activity of Aurora kinase.... |
| AZD1480 |
935666-88-9 |
AZD1480 is a potent ATP competitive inhibitor of JAK2 kinase, with an inhibition constant (Ki) of 0.26 nM.... |
| AZD1480 |
935666-88-9 |
AZD1480 is a potent ATP competitive inhibitor of JAK2 kinase, with an inhibition constant (Ki) of 0.26 nM.... |
| AZD1480 |
935666-88-9 |
AZD1480 is a potent ATP competitive inhibitor of JAK2 kinase, with an inhibition constant (Ki) of 0.26 nM.... |
| AZD1480 |
935666-88-9 |
AZD1480 is a potent ATP competitive inhibitor of JAK2 kinase, with an inhibition constant (Ki) of 0.26 nM.... |
| AZD2281 |
763113-22-0 |
AZD2281 is a poly ADP-ribose polymerase (PARP) inhibitor.... |
| AZD2281 |
763113-22-0 |
AZD2281 is a poly ADP-ribose polymerase (PARP) inhibitor.... |
| AZD2281 |
763113-22-0 |
AZD2281 is a poly ADP-ribose polymerase (PARP) inhibitor.... |
| AZD2461 |
1174043-16-3 |
AZD2461 is a novel PARP (poly (ADP-ribose) polymerase) inhibitor.... |
| AZD2461 |
1174043-16-3 |
AZD2461 is a novel PARP (poly (ADP-ribose) polymerase) inhibitor.... |
| AZD2858 |
486424-20-8 |
.... |
| Belinostat |
414864-00-9 |
Belinostat is a novel hydroxamate-type inhibitor of histone deacetylase activity.... |
| Belinostat |
414864-00-9 |
Belinostat is a novel hydroxamate-type inhibitor of histone deacetylase activity.... |
| Belinostat |
414864-00-9 |
Belinostat is a novel hydroxamate-type inhibitor of histone deacetylase activity.... |
| Belinostat |
414864-00-9 |
Belinostat is a novel hydroxamate-type inhibitor of histone deacetylase activity.... |
| BIO |
667463-62-9 |
.... |
| BIX-01294 |
935693-62-2 |
BIX-01294 is a specific G9a histone methyltransferase inhibitor.... |
| BIX-01294 |
935693-62-2 |
BIX-01294 is a specific G9a histone methyltransferase inhibitor.... |
| BSI-201 |
160003-66-7 |
BSI-201 is an irreversible inhibitor of PARP1.... |
| BSI-201 |
160003-66-7 |
BSI-201 is an irreversible inhibitor of PARP1.... |
| BSI-201 |
160003-66-7 |
BSI-201 is an irreversible inhibitor of PARP1.... |
| Canertinib dihydrochloride |
289499-45-2 |
.... |
| CCT137690 |
1095382-05-0 |
CCT137690 is a potent and selective inhibitor of Aurora kinases.... |
| CCT137690 |
1095382-05-0 |
CCT137690 is a potent and selective inhibitor of Aurora kinases.... |
| CEP18770 |
847499-27-8 |
.... |
| CHR-3996 |
1235859-13-8 |
CHR-3996 is a class I selective orally active histone deacetylase (HDAC) inhibitor with an IC50 of 8 nM.... |
| CI994 |
112522-64-2 |
CI-994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 μM and causes G1 cell cycle arrest, and CI-994 is in Phase III clinical trial in patients with Lung Cancer [1].... |
| CI994 |
112522-64-2 |
CI-994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 μM and causes G1 cell cycle arrest, and CI-994 is in Phase III clinical trial in patients with Lung Cancer [1].... |
| CP690550 |
477600-75-2 |
.... |
| CUDC-101 |
1012054-59-9 |
CUDC-101 is a potent HDAC, EGFR and HER2 inhibitor with IC50 values of 4.4, 2.4, and 15.7 nM, respectively.... |
| CUDC-101 |
1012054-59-9 |
CUDC-101 is a potent HDAC, EGFR and HER2 inhibitor with IC50 values of 4.4, 2.4, and 15.7 nM, respectively.... |
| CUDC-101 |
1012054-59-9 |
CUDC-101 is a potent HDAC, EGFR and HER2 inhibitor with IC50 values of 4.4, 2.4, and 15.7 nM, respectively.... |
| CUDC-907 |
1339928-25-4 |
CUDC-907 is a potent inhibitor of both HDAC and PI3K.... |
| CUDC-907 |
1339928-25-4 |
CUDC-907 is a potent inhibitor of both HDAC and PI3K.... |
| CUDC-907 |
1339928-25-4 |
CUDC-907 is a potent inhibitor of both HDAC and PI3K.... |
| CUDC-907 |
1339928-25-4 |
CUDC-907 is a potent inhibitor of both HDAC and PI3K.... |
| CYT387 |
1056634-68-4 |
CYT387 is an ATP-competitive inhibitor of JAK1 and JAK2 with IC50 of 11 and 18 nM, respectively.... |
| CYT387 |
1056634-68-4 |
CYT387 is an ATP-competitive inhibitor of JAK1 and JAK2 with IC50 of 11 and 18 nM, respectively.... |
| CYT387 |
1056634-68-4 |
CYT387 is an ATP-competitive inhibitor of JAK1 and JAK2 with IC50 of 11 and 18 nM, respectively.... |
| Danusertib(PHA-739358) |
827318-97-8 |
Danusertib is a small-molecule 3-aminopyrazole derivative with strong activity against Aurora kinases with IC50 of 13, 79, and 61 nM for Aurora A, B, and C, respectively.... |
| Danusertib(PHA-739358) |
827318-97-8 |
Danusertib is a small-molecule 3-aminopyrazole derivative with strong activity against Aurora kinases with IC50 of 13, 79, and 61 nM for Aurora A, B, and C, respectively.... |
| Danusertib(PHA-739358) |
827318-97-8 |
Danusertib is a small-molecule 3-aminopyrazole derivative with strong activity against Aurora kinases with IC50 of 13, 79, and 61 nM for Aurora A, B, and C, respectively.... |
| Decitabine |
2353-33-5 |
Decitabine is a DNA methyltransferase inhibitor.... |
| Decitabine |
2353-33-5 |
Decitabine is a DNA methyltransferase inhibitor.... |
| Decitabine |
2353-33-5 |
Decitabine is a DNA methyltransferase inhibitor.... |
| Decitabine |
2353-33-5 |
Decitabine is a DNA methyltransferase inhibitor.... |
| ENMD-2076 |
1291074-87-7 |
ENMD-2076 is a potent inhibitor of Aurora A and Aurora B with IC50s of 14 and 350 nM, respectively.... |
| ENMD-2076 |
1291074-87-7 |
ENMD-2076 is a potent inhibitor of Aurora A and Aurora B with IC50s of 14 and 350 nM, respectively.... |
| ENMD-2076 |
1291074-87-7 |
ENMD-2076 is a potent inhibitor of Aurora A and Aurora B with IC50s of 14 and 350 nM, respectively.... |
| ENMD-2076 |
1291074-87-7 |
ENMD-2076 is a potent inhibitor of Aurora A and Aurora B with IC50s of 14 and 350 nM, respectively.... |
| Entinostat |
209783-80-2 |
Entinostat is an oral class I isoform-selective histone deacetylases (HDAC) inhibitor with IC50s of 0.51 and 1.7 µM for HDAC1 and HDAC3, respectively.... |
| Entinostat |
209783-80-2 |
Entinostat is an oral class I isoform-selective histone deacetylases (HDAC) inhibitor with IC50s of 0.51 and 1.7 µM for HDAC1 and HDAC3, respectively.... |
| Entinostat |
209783-80-2 |
Entinostat is an oral class I isoform-selective histone deacetylases (HDAC) inhibitor with IC50s of 0.51 and 1.7 µM for HDAC1 and HDAC3, respectively.... |
| Entinostat |
209783-80-2 |
Entinostat is an oral class I isoform-selective histone deacetylases (HDAC) inhibitor with IC50s of 0.51 and 1.7 µM for HDAC1 and HDAC3, respectively.... |
| EPZ005687 |
1396772-26-1 |
EPZ005687 is a potent and selective small-molecule inhibitor of enhancer of zeste homolog 2 (EZH2).... |
| EPZ005687 |
1396772-26-1 |
EPZ005687 is a potent and selective small-molecule inhibitor of enhancer of zeste homolog 2 (EZH2).... |
| EX 527 |
49843-98-3 |
EX-527 is a potent and specific small-molecule inhibitor of SIRT1.... |
| Givinostat |
732302-99-7 |
Givinostat is a potent inhibitor of HDAC with IC50 values of 10, 7.5 and 16 nM for HD2, HD1-B and HD1-A, respectively.... |
| Givinostat |
732302-99-7 |
Givinostat is a potent inhibitor of HDAC with IC50 values of 10, 7.5 and 16 nM for HD2, HD1-B and HD1-A, respectively.... |
| Givinostat |
732302-99-7 |
Givinostat is a potent inhibitor of HDAC with IC50 values of 10, 7.5 and 16 nM for HD2, HD1-B and HD1-A, respectively.... |
| Givinostat |
732302-99-7 |
Givinostat is a potent inhibitor of HDAC with IC50 values of 10, 7.5 and 16 nM for HD2, HD1-B and HD1-A, respectively.... |
| GSK J4 |
1373423-53-0 |
.... |
| GSK1070916 |
942918-07-2 |
GSK1070916 is a novel, potent and selective ATP competitive inhibitor of Aurora B and Aurora C kinases with IC50 values of 3.5 and 6.5 nM, respectively.... |
| GSK1070916 |
942918-07-2 |
GSK1070916 is a novel, potent and selective ATP competitive inhibitor of Aurora B and Aurora C kinases with IC50 values of 3.5 and 6.5 nM, respectively.... |
| GSK1070916 |
942918-07-2 |
GSK1070916 is a novel, potent and selective ATP competitive inhibitor of Aurora B and Aurora C kinases with IC50 values of 3.5 and 6.5 nM, respectively.... |
| GSK1070916 |
942918-07-2 |
GSK1070916 is a novel, potent and selective ATP competitive inhibitor of Aurora B and Aurora C kinases with IC50 values of 3.5 and 6.5 nM, respectively.... |
| GSK343 |
1346704-33-3 |
.... |
| GSK343 |
1346704-33-3 |
.... |
| Hesperadin |
422513-13-1 |
Hesperadin is an indolinone inhibitor of human Aurora B with an IC50 of 250 nM.... |
| Hesperadin |
422513-13-1 |
Hesperadin is an indolinone inhibitor of human Aurora B with an IC50 of 250 nM.... |
| Hesperadin |
422513-13-1 |
Hesperadin is an indolinone inhibitor of human Aurora B with an IC50 of 250 nM.... |
| Hesperadin |
422513-13-1 |
Hesperadin is an indolinone inhibitor of human Aurora B with an IC50 of 250 nM.... |
| INCB018424 |
941678-49-5 |
INCB018424 is a potent and selective inhibitor of JAK1 (Janus kinase) and JAK2 with IC50 of 3.3 and 2.8 nM, respectively.... |
| INCB018424 |
941678-49-5 |
INCB018424 is a potent and selective inhibitor of JAK1 (Janus kinase) and JAK2 with IC50 of 3.3 and 2.8 nM, respectively.... |
| INCB018424 |
941678-49-5 |
INCB018424 is a potent and selective inhibitor of JAK1 (Janus kinase) and JAK2 with IC50 of 3.3 and 2.8 nM, respectively.... |
| INCB018424 |
941678-49-5 |
INCB018424 is a potent and selective inhibitor of JAK1 (Janus kinase) and JAK2 with IC50 of 3.3 and 2.8 nM, respectively.... |
| INO-1001 |
3544-24-9 |
INO-1001 is a potent poly(ADP-ribose) polymerase (PARP) inhibitor.... |
| JQ1 |
1268524-70-4 |
JQ1 is a small molecule inhibitor of BET bromodomains.... |
| JQ1 |
1268524-70-4 |
JQ1 is a small molecule inhibitor of BET bromodomains.... |
| LAQ824 |
404951-53-7 |
.... |
| LBH-589 |
404950-80-7 |
LBH589 is a novel histone deacetylase (HDAC) inhibitor with an IC50 value of 30 nM.... |
| LBH-589 |
404950-80-7 |
LBH589 is a novel histone deacetylase (HDAC) inhibitor with an IC50 value of 30 nM.... |
| LBH-589 |
404950-80-7 |
LBH589 is a novel histone deacetylase (HDAC) inhibitor with an IC50 value of 30 nM.... |
| LY2784544 |
1229236-86-5 |
LY2784544 has been identified as being highly selective for JAK 2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.... |
| LY2784544 |
1229236-86-5 |
LY2784544 has been identified as being highly selective for JAK 2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.... |
| LY2784544 |
1229236-86-5 |
LY2784544 has been identified as being highly selective for JAK 2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.... |
| LY2784544 |
1229236-86-5 |
LY2784544 has been identified as being highly selective for JAK 2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.... |
| M344 |
251456-60-7 |
.... |
| MC1568 |
852475-26-4 |
MC1568 is a selective class II (IIa) histone deacetylas (HDAC II) inhibitor.... |
| MC1568 |
852475-26-4 |
MC1568 is a selective class II (IIa) histone deacetylas (HDAC II) inhibitor.... |
| MGCD0103 |
726169-73-9 |
MGCD0103 is an isotype-selective inhibitor of histone deacetylases (HDACs) targeted to isoforms 1, 2, 3, and 11.... |
| MGCD0103 |
726169-73-9 |
MGCD0103 is an isotype-selective inhibitor of histone deacetylases (HDACs) targeted to isoforms 1, 2, 3, and 11.... |
| MGCD0103 |
726169-73-9 |
MGCD0103 is an isotype-selective inhibitor of histone deacetylases (HDACs) targeted to isoforms 1, 2, 3, and 11.... |
| MGCD0103 |
726169-73-9 |
MGCD0103 is an isotype-selective inhibitor of histone deacetylases (HDACs) targeted to isoforms 1, 2, 3, and 11.... |
| MK-4827 |
1038915-64-8 |
MK-4827 is a potent, selective inhibitor of PARP1 and PARP2 with IC50 of 3.8 and 2.1 nM, respectively.... |
| MK-5108 |
1010085-13-8 |
MK-5108 is a potent and selective Aurora A inhibitor with IC50 of 0.064 nM.... |
| MK-5108 |
1010085-13-8 |
MK-5108 is a potent and selective Aurora A inhibitor with IC50 of 0.064 nM.... |
| MK-5108 |
1010085-13-8 |
MK-5108 is a potent and selective Aurora A inhibitor with IC50 of 0.064 nM.... |
| MK-5108 |
1010085-13-8 |
MK-5108 is a potent and selective Aurora A inhibitor with IC50 of 0.064 nM.... |
| MK0752 |
902240-86-2 |
.... |
| MK0752 |
902240-86-2 |
.... |
| MK4827 |
1038915-60-4 |
.... |
| MLN8054 |
869363-13-3 |
MLN8054 is a potent Aurora A inhibitor with an IC50 of 4 nM.... |
| MLN8054 |
869363-13-3 |
MLN8054 is a potent Aurora A inhibitor with an IC50 of 4 nM.... |
| MLN8054 |
869363-13-3 |
MLN8054 is a potent Aurora A inhibitor with an IC50 of 4 nM.... |
| MLN8054 |
869363-13-3 |
MLN8054 is a potent Aurora A inhibitor with an IC50 of 4 nM.... |
| MLN8237 |
1028486-01-2 |
MLN8237 is a selective Aurora A and Aurora B inhibitor with IC50 values of 1.2 and 396.5 nM, respectively.... |
| MLN8237 |
1028486-01-2 |
MLN8237 is a selective Aurora A and Aurora B inhibitor with IC50 values of 1.2 and 396.5 nM, respectively.... |
| MLN8237 |
1028486-01-2 |
MLN8237 is a selective Aurora A and Aurora B inhibitor with IC50 values of 1.2 and 396.5 nM, respectively.... |
| MLN8237 |
1028486-01-2 |
MLN8237 is a selective Aurora A and Aurora B inhibitor with IC50 values of 1.2 and 396.5 nM, respectively.... |
| NU1025 |
90417-38-2 |
NU1025 is a potent poly (ADP-ribose) polymerase (PARP) inhibitor.... |
| OTX015 |
202590-98-5 |
.... |
| Pacritinib |
937272-79-2 |
Pacritinib is a novel oral JAK2 inhibitor.... |
| PCI-24781 |
783355-60-2 |
.... |
| PCI-34051 |
950762-95-5 |
.... |
| PF04217903 |
1159490-85-3 |
.... |
| PF04217903 |
1159490-85-3 |
.... |
| PF562271 |
717907-75-0 |
.... |
| PHA-680632 |
398493-79-3 |
PHA-680632 is a novel, highly selective Aurora kinase inhibitor.... |
| PP121 |
1092788-83-4 |
.... |
| RG108 |
48208-26-0 |
.... |
| SB939 |
929016-96-6 |
SB939 is a potent novel HDACs inhibitor with IC50 values ranging from 40 to 140 nM.... |
| SB939 |
929016-96-6 |
SB939 is a potent novel HDACs inhibitor with IC50 values ranging from 40 to140 nM.... |
| SB939 |
929016-96-6 |
SB939 is a potent novel HDACs inhibitor with IC50 values ranging from 40 to140 nM.... |
| SGC0946 |
|
.... |
| SGC0946 |
|
.... |
| SGI-110 |
929901-49-5 |
SGI-110 is a DNA hypomethylating agent targeting DNA methyltransferase.... |
| SGI1776 |
1025065-69-3 |
SGI-1776 is a novel ATP competitive inhibitor of Pim kinases, which are a family of three vertebrate protein serine/ threonine kinases (Pim-1, -2, and -3) belonging to the CAMK (calmodulin-dependent protein kinase-related) group.... |
| SNS-314 |
1057249-41-8 |
SNS-314 is a potent and selective Aurora kinase inhibitor.... |
| Sodium butyrate |
156-54-7 |
Sodium butyrate is a histone deacetylase (HDAC) inhibitor.... |
| TG101209 |
936091-14-4 |
TG101209 potently inhibits JAK2, FLT3 and RET kinases with IC50 values of 6, 25 and 17 nM, respectively.... |
| TG101209 |
936091-14-4 |
TG101209 potently inhibits JAK2, FLT3 and RET kinases with IC50 values of 6, 25 and 17 nM, respectively.... |
| TG101209 |
936091-14-4 |
TG101209 potently inhibits JAK2, FLT3 and RET kinases with IC50 values of 6, 25 and 17 nM, respectively.... |
| TG101209 |
936091-14-4 |
TG101209 potently inhibits JAK2, FLT3 and RET kinases with IC50 values of 6, 25 and 17 nM, respectively.... |
| TG101348 |
936091-26-8 |
TG101348 is a selective small-molecule inhibitor of JAK2.... |
| TG101348 |
936091-26-8 |
TG101348 is a selective small-molecule inhibitor of JAK2.... |
| TG101348 |
936091-26-8 |
TG101348 is a selective small-molecule inhibitor of JAK2.... |
| TG101348 |
936091-26-8 |
TG101348 is a selective small-molecule inhibitor of JAK2.... |
| Tofacitinib citrate |
540737-29-9 |
Tofacitinib citrate is a PAN-JAK inhibitor with phenomenal selectivity against the human kinome.... |
| Trichostatin A |
58880-19-6 |
Trichostatin A is a potent and specific inhibitor of the histone deacetylase (HDAC).... |
| Trichostatin A |
58880-19-6 |
Trichostatin A is a potent and specific inhibitor of the histone deacetylase (HDAC).... |
| Tubastatin-A-Hydrochloride |
1310693-92-5 |
Tubastatin A is a selective histone deacetylase 6 (HDAC6) inhibitor with an IC50 of 15 nM.... |
| UNC-0638 |
1255517-77-1 |
UNC-0638 is a dual euchromatic histone-lysine N-methyltransferase (EHMT) 1/2 inhibitor.... |
| UNC1999 |
1431612-23-5 |
.... |
| UNC1999 |
1431612-23-5 |
.... |
| UNC669 |
1314241-44-5 |
.... |
| UNC669 |
1314241-44-5 |
.... |
| UPF1069 |
1048371-03-4 |
.... |
| UPF1069 |
1048371-03-4 |
.... |
| Veliparib |
912444-00-9 |
Veliparib is a novel and potent inhibitor of poly (ADP-ribose) polymerase (PARP) -1 and PARP-2 enzymes with Kis of 5.2 and 2.9 nM, respectively.... |
| Veliparib |
912444-00-9 |
Veliparib is a novel and potent inhibitor of poly (ADP-ribose) polymerase (PARP) -1 and PARP-2 enzymes with Kis of 5.2 and 2.9 nM, respectively.... |
| Veliparib |
912444-00-9 |
Veliparib is a novel and potent inhibitor of poly (ADP-ribose) polymerase (PARP) -1 and PARP-2 enzymes with Kis of 5.2 and 2.9 nM, respectively.... |
| Vorinostat |
149647-78-9 |
Vorinostat is a HDAC1 (histone deacetylases) inhibitor.... |
| Vorinostat |
149647-78-9 |
Vorinostat is a HDAC1 (histone deacetylases) inhibitor.... |
| VX-680 |
639089-54-6 |
VX-680 is a highly potent and selective small-molecule inhibitor of Aurora kinases.... |
| VX-680 |
639089-54-6 |
VX-680 is a highly potent and selective small-molecule inhibitor of Aurora kinases.... |
| VX-680 |
639089-54-6 |
VX-680 is a highly potent and selective small-molecule inhibitor of Aurora kinases.... |
| WP1066 |
857064-38-1 |
WP1066 is a novel JAK2 inhibitor.... |
| WP1066 |
857064-38-1 |
WP1066 is a novel JAK2 inhibitor.... |
| Zebularine |
3690/10/6 |
.... |
| ZM-447439 |
331771-20-1 |
ZM-447439 is an Auroa selective ATP-competitive inhibitor that interferes with the spindle integrity checkpoint and chromosome segregation.... |
| ZM-447439 |
331771-20-1 |
ZM-447439 is an Auroa selective ATP-competitive inhibitor that interferes with the spindle integrity checkpoint and chromosome segregation.... |
| ZM-447439 |
331771-20-1 |
ZM-447439 is an Auroa selective ATP-competitive inhibitor that interferes with the spindle integrity checkpoint and chromosome segregation.... |
| ZM-447439 |
331771-20-1 |
ZM-447439 is an Auroa selective ATP-competitive inhibitor that interferes with the spindle integrity checkpoint and chromosome segregation.... |
点击图片查看原图
